See inside every stock. Pro
S&P 5007,723▲ 0.60%Nasdaq26,478▲ 1.18%Dow Jones52,378▲ 0.03%Nasdaq 10029,651▲ 1.29%VIX17.52▼ 4.73%US Dollar102.35▲ 0.39%Gold spot4,006▲ 0.30%WTI101.08▲ 1.18%
Euronext Paris · France · Updated after 27 Oct 2026 close

Eurobio Scientific SA

ALERS · Euronext Paris · prices in EUR
EUR 26.40▲ +1.10 (4.35%)
Research reportHistorical data

About Eurobio Scientific SA

Eurobio Scientific is a French in vitro diagnostics company based near Paris. It designs, manufactures and markets diagnostic test kits and reagents used by hospital laboratories and clinical testing services, with a focus on infectious disease testing and transplantation monitoring. The company also distributes specialised life science products and instruments to research and clinical customers, combining its own branded tests with products sourced from partner manufacturers for laboratories in France and other markets.

The shares are listed on the Euronext Paris in France under the code ALERS, and the price on this page is in euros (EUR). Our records, which start in 2019, show no dividend payments for it. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.

76/ 100
Market X-Ray · price-based
Strong price profile
Ranks #42 of 625 on the Euronext Paris · confidence High
What this score is, and is not
It describes how this stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is. That fundamental X-Ray needs financial statements, which we do not have for France yet.
TrendStrong
89/100
Trading above its long-term averages and near its highs.
See the numbers →
Above 200-day average16.9%
From 52-week high0.0%
MomentumStrong
81/100
Rising faster than most stocks on this exchange.
See the numbers →
3-month return23.9%
6-month return10.5%
12-month, skipping last month3.1%
Stability (higher is calmer)Fair
66/100
Typical risk for this exchange.
See the numbers →
Volatility, 1 year (lower is calmer)36.2%
Worst drawdown, 1 year (smaller is calmer)-22.7%
LiquidityFair
64/100
Moderate trading activity.
See the numbers →
Avg daily value traded0.10M EUR
Zero-volume days0.0%
IncomeNone
–/100
Pays no dividend.
See the numbers →
Years with dividends0
Price-based X-Ray. The fundamental X-Ray (financial health, valuation, growth, fair value) is available for US stocks today. It will follow for France when fundamentals data for this market is added. All France stocks.
Price trend
Uptrend
Versus its 50- and 200-day averages
52-week range
19.20 – 26.50
Price is 99% of the way up
Returns
+23.9% 3m · +8.4% 1y
Price returns, dividends not included
RSI (14)
84
Overbought zone

Price chart

52-wk range 19.20 – 26.50 Daily closes, split-adjusted

Signals

50-day average23.03
200-day average22.58
Golden/death cross (60d)Golden, 5 days ago
New 52-week highYes
Bullish RSI divergenceNo
Average daily range (ATR)0.33

Technical summary

Daily
Bullish
12 bullish · 0 neutral · 4 bearish
Weekly
Strongly bullish
11 bullish · 1 neutral · 0 bearish
Monthly
Strongly bullish
7 bullish · 1 neutral · 0 bearish
Moving averages (daily)
SMA 1025.34Bullish
EMA 1025.42Bullish
SMA 2025.26Bullish
EMA 2025.04Bullish
SMA 5023.03Bullish
EMA 5023.79Bullish
SMA 10022.21Bullish
EMA 10023.00Bullish
SMA 20022.58Bullish
EMA 20022.90Bullish
Oscillators (daily)
RSI (14)84.24Bearish
MACD (12, 26)0.61Bullish
Momentum (12)4.76Bullish
Stochastic %K (14)92.86Bearish
Williams %R (14)-7.14Bearish
CCI (20)599.6Bearish
Pivot points (classic, last session)
S3
26.10
S2
26.20
S1
26.30
Pivot
26.40
R1
26.50
R2
26.60
R3
26.70
Signals describe what the chart is doing, not what to do. Moving averages: price above the average is bullish. Oscillators use the usual thresholds (RSI 30/70, Stochastic 20/80, CCI ±100, Williams %R −80/−20; MACD and momentum above zero are bullish). Weekly and monthly views use closing prices only.

Prices are end-of-day closes in EUR. Educational only, not financial advice.